Assessment of the Effectiveness of Vibroacoustic Therapy for Respiratory Failure Caused by COVID 19

Not Applicable

• Conditions: Hypoxemia; Respiratory Distress Syndrome
• Interventions: Device: VibroLUNG

• Registration Number: NCT04435353
• Lead Sponsor: Astana Medical University

Brief Summary

Vibroacoustic pulmonary therapy in patients with COVID19 is believed to have a positive effect on oxygen status and a decrease in the duration of respiratory failure

Detailed Description

This study aims to recruit the required number of patients for statistical identification of the effectiveness of vibroacoustic therapy in patients with COVID 19. Obligatory performance criteria will be presented by the duration of the course of respiratory failure and the duration of mechanical ventilation in the main and control groups. Optional performance criteria will be represented by oximetry values and standardization of laboratory parameters

Study Timeline

• Study Start: 2020-03-22
• Status Verified: 2020-06
• Study First Submitted: 2020-06-14
• Study First Submitted QC: 2020-06-16
• Last Update Submitted: 2020-06-16
• Study First Posted: 2020-06-17
• Last Update Posted: 2020-06-17
• Primary Completion: 2020-12-31
• Study Completion: 2021-02-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

1. adults
2. P/F less 300 torr
3. ARDS by Berlin convention
4. COVID 19 bilateral pneumonia

Exclusion Criteria

1. children
2. acute brain stroke
3. acute coronary syndrome
4. pulmonary embolism
5. implanted pacemaker

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Oxugen support	VibroLUNG	FiO2
Oxygen status	VibroLUNG	Facultative data
Time-day of respiratory fail	VibroLUNG	Objective data
Adverse outcomes	VibroLUNG	Complication

Primary Outcome Measures

Name	Time	Method
Recovery respiratory fail	5-7 days	Regression of respiratory failure under the influence of vibroacoustic therapy

Trial Locations

Locations (2)

Mukatova Irina; 🇰🇿 Astana, Nur-Sultan, Kazakhstan

Center of pulmonology Astana; 🇰🇿 Astana, Kazakhstan